|
Disease-Modifying Therapies (DMTs) Clinical Trials
1 actively recruiting trial across 1 location
No change since July 2026
Top Sponsors
- SetPoint Medical Corporation1
Indications
- Relapsing Remitting Multiple Sclerosis1
- Multiple Sclerosis1
Irvine, California1 trial
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
University of California Irvine Center for Clinical Research
N/A
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.